Cellosaurus logo
expasy logo

Cellosaurus KS24.22 (CVCL_E6X8)

[Text version]
Cell line name KS24.22
Accession CVCL_E6X8
Resource Identification Initiative To cite this cell line use: KS24.22 (RRID:CVCL_E6X8)
Comments Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
HLA typing Source: PubMed=11358828
Class I
HLA-AA*02:01
Disease Breast adenocarcinoma (NCIt: C5214)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_E6X7 (KS24)
Sex of cell Female
Age at sampling Age unspecified
Category Cancer cell line
Web pages Info; ClinicalTrials.gov; NCT01127074; https://clinicaltrials.gov/study/NCT01127074
Publications

PubMed=11358828
Pascolo S., Schirle M., Guckel B., Dumrese T., Stumm S., Kayser S., Moris A., Wallwiener D., Rammensee H.-G., Stevanovic S.
A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry.
Cancer Res. 61:4072-4077(2001)

PubMed=15365776; DOI=10.1007/s00262-004-0583-z; PMCID=PMC11034349
Guckel B., Stumm S., Rentzsch C., Marme A., Mannhardt G., Wallwiener D.
A CD80-transfected human breast cancer cell variant induces HER-2/neu-specific T cells in HLA-A*02-matched situations in vitro as well as in vivo.
Cancer Immunol. Immunother. 54:129-140(2005)

Entry history
Entry creation10-Apr-2025
Last entry update10-Apr-2025
Version number1